COVID-19 and comorbidities: a systematic review and meta-analysis

References

• World Health O Novel Coronavirus (2019-nCoV): situation report, 91. Geneva: World Health Organization; 2020.
   Google Scholar
• Moola SMZ, Tufanaru C, Aromataris E, et al. Joanna Briggs institute reviewer’s manual: the Joanna Briggs institute; 2017 [cited 2020 May 4]. Available from: https://reviewersmanual.joannabriggs.org/.
   Google Scholar
• COVID-19, Australia: epidemiology Report 10 (Reporting week to 23:59 AEST 5 April 2020). Commun Dis Intell (2018). 2020 Apr 9;44.
   Google Scholar
• Report on the Epidemiological Features of Coronavirus Disease. 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci. 2020 Mar 16;35(10): e112
   PubMed Web of Science ®Google Scholar
• Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep.  CDC COVID-19 Response Team; 2020 Apr 3;69(13): 382–386.
   PubMed Web of Science ®Google Scholar
• Analysis on 54 mortality cases of coronavirus disease 2019 in the Republic of Korea from January 19 to March 10, 2020. J Korean Med Sci. The Korean Academy of Medical Sciences; 2020 Mar 30;35(12):e132
   PubMed Web of Science ®Google Scholar
• Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb 15;395(10223):514–523.
   PubMed Web of Science ®Google Scholar
• Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020 Mar 7;395(10226):809–815.
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar;26(368):m1091
   Web of Science ®Google Scholar
• Gupta N, Agrawal S, Ish P, et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Arch Chest Dis. 2020 Apr 10;90(1). DOI:10.4081/monaldi.2020.1294.
   Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Kimball A, Hatfield KM, Arons M, et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility - King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):377–381.
   PubMed Web of Science ®Google Scholar
• Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 [Article in press]. Thromb Res. 2020;191:145–147.
   Web of Science ®Google Scholar
• Lei S, Jiang F, Su W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection [Article in press]. EClinicalMedicine. 2020;21.
   Google Scholar
• Li R, Tian J, Yang F, et al. Clinical characteristics of 225 patients with COVID-19 in a tertiary hospital near Wuhan, China [Article]. J Clin Virol. 2020;127.
   Web of Science ®Google Scholar
• Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 Mar;21(3):335–337
   PubMed Web of Science ®Google Scholar
• Lo IL, Lio CF, Cheong HH, et al. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau. Int J Biol Sci. 2020;16(10):1698–1707
   PubMed Web of Science ®Google Scholar
• McMichael TM, Clark S, Pogosjans S, et al. COVID-19 in a long-term care facility - King County, Washington, February 27-March 9, 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):339–342.
   PubMed Web of Science ®Google Scholar
• Pung R, Chiew CJ, Young BE, et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet. 2020 Mar 28;395(10229):1039–1046.
   PubMed Web of Science ®Google Scholar
• Shi Y, Yu X, Zhao H, et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Crit Care. 2020 Mar 18;24(1):108.
   PubMed Web of Science ®Google Scholar
• Spiteri G, Fielding J, Diercke M, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European region, 24 January to 21 February 2020. Euro Surveill. 2020 Mar;25(9):9
   Google Scholar
• Tian S, Hu N, Lou J, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020 Apr;80(4):401–406
   PubMed Web of Science ®Google Scholar
• Wang K, Kang S, Tian R, et al. Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area. Clin Radiol. 2020 May;75(5):341–347
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen X, Lu Y, et al. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020 Mar 16;14(1):64–68.
   PubMed Web of Science ®Google Scholar
• Xia W, Shao J, Guo Y, et al. Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults. Pediatr Pulmonol. 2020 May;55(5):1169–1174
   PubMed Web of Science ®Google Scholar
• Xu X, Yu C, Qu J, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275–1280
   PubMed Web of Science ®Google Scholar
• Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020 Feb;19(368):m606
   Web of Science ®Google Scholar
• Yang P, Wang X, Liu P, et al. Clinical characteristics and risk assessment of newborns born to mothers with COVID-19 [Article]. J Clin Virol. 2020;127.
   Web of Science ®Google Scholar
• Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020 Apr;80(4):388–393
   PubMed Web of Science ®Google Scholar
• Yuan M, Yin W, Tao Z, et al. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One. 2020;15(3):e0230548
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhong Z, Xie X, et al. CT scans of patients with 2019 novel coronavirus (covid-19) pneumonia [Article]. Theranostics. 2020;10(10):4606–4613
   PubMed Web of Science ®Google Scholar
• Zheng F, Tang W, Li H, et al. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3404–3410
   PubMed Web of Science ®Google Scholar
• Zhong Q, Liu YY, Luo Q, et al. Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study [Article in Press]. Br J Anaesth. 2020;124(6):670–675
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020 Apr 16;181(2):271–280.e8.
   PubMed Web of Science ®Google Scholar
• Danser AHJ, Epstein M, Batlle D. Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension. 2020 Jun;75(6):1382–1385.
   PubMed Web of Science ®Google Scholar
• Ferrario CM, Jessup J, Chappell MC, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005 May 24;111(20):2605–2610.
   PubMed Web of Science ®Google Scholar
• Youn JC, Yu HT, Lim BJ, et al. Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension. 2013 Jul;62(1):126–133
   PubMed Web of Science ®Google Scholar
• Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: the conundrum. Diabetes Res Clin Pract. 2020;162.
   Google Scholar
• Tikellis C, Thomas MC. Angiotensin-Converting Enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012 March 20;2012:256294
   PubMedGoogle Scholar
• Zou Z, Yan Y, Shu Y, et al. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun. 2014 May 6;5(1):3594.
   PubMed Web of Science ®Google Scholar
• Zangrillo A, Beretta L, Scandroglio AM, et al. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Apr 23.
   Web of Science ®Google Scholar
• Diamond M, Feliciano HLP, Sanghavi D, et al. Acute Respiratory Distress Syndrome (ARDS). Florida, United States of America: StatPearls Publishing; 2020.
   Google Scholar
• Li X, Molina-Molina M, Abdul-Hafez A, et al. Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L178–85
   PubMed Web of Science ®Google Scholar
• Leung JM, Yang CX, Tam A, et al. ACE-2 expression in the small airway epithelia of smokers and COPD Patients: implications for COVID-19. Eur Respir J. 2020 Apr 8;55(5):2000688.
   Web of Science ®Google Scholar
• Ansa BE, Hoffman Z, Lewis N, et al. Aspirin use among adults with cardiovascular disease in the United States: implications for an intervention approach. J Clin Med. 2019 Feb 20;8(2):264.
   PubMed Web of Science ®Google Scholar
• Müller C, Karl N, Ziebuhr J, et al. D, L-lysine acetylsalicylate + glycine impairs Coronavirus replication. J Antivirals Antiretrovirals. 2016 Dec;30:2016.
   Google Scholar
• Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. Jama. 2001 Jul 4;286(1):64–70.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Lowenthal SP. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation. 2001 Mar 6;103(9):1191–1193.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Pfeffer MA, et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) investigators. Circulation. 1999 Jul 20;100(3):230–235.
   PubMed Web of Science ®Google Scholar
• Chen L, Li X, Chen M, et al. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020 May 1;116(6):1097–1100.
   PubMed Web of Science ®Google Scholar
• Guo J, Huang Z, Lin L, et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome Coronavirus 2 infection. J Am Heart Assoc. 2020 Apr 7;9(7):e016219.
   PubMed Web of Science ®Google Scholar